IRCT2016070628814N1 IRCT 2016-07-17 Vice chancellor for research, Mashhad University of Medical Sciences The effects of enoxaparin in treatment of esophageal cancer The effect of addition of enoxaparin to neoadjuvant chemoradiation of esophageal cancer on the clinical and pathologic response and value of post-chemoradiation findings in prediction of complete pathologic response 2016-07-22 anticipated 100 Complete https://irct.ir/trial/23280 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Random allocation and blinding was done this way: using a computerized random number table, patients are going to assign to intervention or control groups. Patient are going to be blind about their interventions. Thus, this study is a randomized and single-blind. 2 Condition 1: Malignant neoplasm of oesophagus. Condition 2: Follow-up examination after combined treatment for malignant neoplasm. Intervention 1: In the intervention group, patients are going to receive subcutaneous enoxaparin (40 mg) daily concurrent with chemo-radiotherapy. Intervention 2: chemo-radiotherapy.